Campbell & Co Investment Adviser’s Ascendis Pharma A/S ASND Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.7M	Buy	+6,365	New	+$1.49M	0.09%	368
2026 Q1	–	Sell	-2,294	Closed	-$489K	–	1061
2025 Q4	$489K	Sell	2,294 -9,715	-81%	-$2.01M	0.02%	837
2025 Q3	$2.39M	Buy	+12,009	New	+$2.24M	0.18%	133
2025 Q2	–	Sell	-13,036	Closed	-$2.03M	–	1132
2025 Q1	$2.03M	Buy	13,036 +7,001	+116%	+$1M	0.16%	197
2024 Q4	$831K	Sell	6,035 -441	-7%	-$58K	0.06%	464
2024 Q3	$967K	Sell	6,476 -10,784	-62%	-$1.46M	0.07%	455
2024 Q2	$2.35M	Buy	+17,260	New	+$2.35M	0.2%	124
2024 Q1	–	Sell	-3,997	Closed	-$503K	–	1094
2023 Q4	$503K	Buy	+3,997	New	+$399K	0.05%	710
2021 Q4	–	Sell	-2,900	Closed	-$462K	–	615
2021 Q3	$462K	Buy	+2,900	New	+$397K	0.15%	240

Other funds holding ASND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Campbell & Co Investment Adviser's ASND Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 6,365 shares worth $1.7M. The stake represents 0.09% of the portfolio and ranks #368 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in ASND as recently as Q4 2025.

Campbell & Co Investment Adviser first reported a position in ASND in Q3 2021 and has held it in 9 quarters since. The position peaked at $2.39M in Q3 2025. 107 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Campbell & Co Investment Adviser held 6,365 shares of Ascendis Pharma A/S worth $1.7M as of Q2 2026.
Ascendis Pharma A/S was a new Campbell & Co Investment Adviser position in Q2 2026.
Ascendis Pharma A/S made up 0.09% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #368 holding.
Campbell & Co Investment Adviser first reported a position in Ascendis Pharma A/S in Q3 2021 and has held it in 9 quarters since.
Campbell & Co Investment Adviser's Ascendis Pharma A/S position peaked at $2.39M in Q3 2025.
107 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.